Menu
Back to Journals » OncoTargets and Therapy » Volume 7
Original Research
Continuation of bevacizumab and addition of hormone therapy following weekly paclitaxel therapy in HER2-negative metastatic breast cancer
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 9,980 | Dovepress* | 9,275+ | 1,097 | 10,372 | |
| PubMed Central* | 705 | 315 | 1,020 | ||
| Totals | 9,980 | 1,412 | 11,392 | ||
|
*Since 27 November 2014 +Since July 2016 |
|||||
View citations on PubMed Central and Google Scholar